Add BrightSurf on Google Email

New drug shows promise in treating liver disease caused by metabolic dysfunction, cancer

A new drug candidate has been developed to target and eliminate senescent cells in the liver, reducing fat buildup and preventing liver damage. The study demonstrates a safer and more effective approach to treating metabolic dysfunction-associated steatotic liver disease (MASLD) and potentially inhibiting liver cancer development.

Diabetes drug could help cancer patients make better recovery

A new study published in the European Journal of Preventive Cardiology found that a type of diabetes medication called SGLT2 inhibitors can significantly lower the risk of heart failure and hospital visits related to heart failure in cancer patients. The benefits were particularly promising for breast cancer patients receiving anthracy...

SourceUniversity of East Anglia·JournalEuropean Journal of Preventive Cardiology·TypeMeta-analysis·DateMar 5, 2025

We feed gut microbes sugar, they make a compound we need

Researchers at Kobe University discovered that gut microbes convert glucose into short-chain fatty acids when fed sugar, highlighting a new symbiotic relationship. This finding could lead to the development of novel therapeutics for regulating gut microbiota and their metabolites.

SourceKobe University·JournalCommunications Medicine·TypeExperimental study·DateMar 3, 2025

Prevalence and control of diabetes among US adults

The study found that the prevalence of adults with diabetes did not significantly change between 2013 and 2023. However, glycemic control among those with diagnosed disease worsened, particularly among young adults. This trend is concerning due to its potential impact on lifetime risk of cardiovascular events.

SourceJAMA Network·JournalJAMA·DateFeb 27, 2025

Causal relationship between type II diabetes mellitus, metformin, insulin, gliclazide, and esophageal cancer—insights from two-sample Mendelian randomization study and meta-analysis

A genetic predisposition to type II diabetes mellitus is associated with a reduced risk of esophageal cancer. Metformin use has been shown to decrease the prevalence of esophageal cancer, while insulin and gliclazide have no significant association.

SourceNational Center for Respiratory Medicine·JournalJournal of Thoracic Disease·TypeObservational study·DateFeb 25, 2025

Researchers uncover surprising link to stroke risk

A new study from the University of Texas at Arlington found that Americans aged 65 and older who experienced parental divorce as children were more likely to suffer a stroke compared to their peers. The study analyzed data from over 13,000 older Americans and found that about 14% had experienced parental divorce during childhood.

SourceUniversity of Texas at Arlington·JournalPLOS One·TypeData/statistical analysis·DateFeb 18, 2025

Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes

A new study found high discordance among clinical experts on interpreting CGM reports from individuals without diabetes, highlighting the need for more research and guidelines. Experts recommend follow-up and specific reasoning for their decisions, despite having extensive CGM experience.

SourceBoston University School of Medicine·JournalJournal of Diabetes Science and Technology·TypeSurvey·DateFeb 18, 2025

Brain network disorders review uncovers the link between metabolic disorders and Alzheimer's disease

Researchers explore the connection between Alzheimer's and metabolic syndrome, finding links between insulin regulation, high blood pressure, and obesity. The study suggests that maintaining healthy blood fat levels may be crucial for brain health, paving way for potential therapeutic developments.

SourceBrain Network Disorders Editorial Office·JournalBrain Network Disorders·TypeLiterature review·DateFeb 18, 2025

Inadequate postpartum screening for hypertension and diabetes a ‘missed opportunity’ for women, study suggests

A new study published in Circulation suggests that less than one in five patients are tested for cardiovascular risk factors following pregnancy-related hypertension or diabetes. This leaves women without adequate screening for high blood pressure, lipids, and sugars, increasing their risk of future stroke or heart disease.

SourceInstitute for Clinical Evaluative Sciences·JournalCirculation·TypeObservational study·DateFeb 17, 2025

Mouse study finds impaired cell development: Intermittent fasting could be unsafe for teenagers

A recent study reveals that intermittent fasting can impair beta-cell function and maturation in young mice, potentially leading to diabetes. Researchers found that adolescent mice showed a decline in insulin production after prolonged fasting, with defective beta cells resembling those of type 1 diabetes patients.

SourceTechnical University of Munich (TUM)·JournalCell Reports·TypeExperimental study·DateFeb 14, 2025

A new switch for the cell therapies of the future

Researchers have developed a new gene switch that uses nitroglycerine to trigger the production of insulin and regulate blood sugar levels in people with diabetes. This switch is made exclusively of human constituents, eliminating the risk of false triggering or immune reactions.

SourceETH Zurich·JournalNature Biomedical Engineering·DateFeb 14, 2025

New study finds lower cardiovascular risk in Type 1 diabetes compared to Type 2 diabetes

A new study published in JSCAI reveals a lower risk of cardiovascular events for people with Type 1 diabetes, compared to those with Type 2 diabetes. The research highlights the importance of distinguishing between the two types of diabetes and developing targeted treatment strategies.

SourceSociety for Cardiovascular Angiography and Interventions·JournalJournal of the Society for Cardiovascular Angiography & Interventions·DateFeb 12, 2025

New details about insulin production deciphered

Scientists at the University of Würzburg have discovered that fruit fly nerve cells release insulin into the haemolymph when ingesting sugar, not when it's injected directly. This phenomenon is similar to the incretin effect in humans, suggesting complex mechanisms controlling insulin secretion.

SourceUniversity of Würzburg·JournaleLife·TypeExperimental study·DateFeb 5, 2025

Diabetes-linked amputations surge in Oklahoma amid national decline, OU study finds

A new University of Oklahoma study found that diabetes-linked amputations are rising in Oklahoma, with the statewide rate nearly doubling between 2008 and 2019. The study analyzed over 1.3 million anonymized discharge records and found that rates were highest among males, American Indians, and those with poor health insurance coverage.

SourceUniversity of Oklahoma·JournalJournal of Vascular Surgery·TypeObservational study·DateFeb 4, 2025

The European Society For Paediatric Endocrinology and the European Society Of Endocrinology join together in 2025 to launch the first joint Congress – “Connecting Endocrinology Across The Life Course”

The European Society for Paediatric Endocrinology and the European Society of Endocrinology will host the first-ever joint Congress on May 10-13, 2025. The event aims to bring together paediatric and adult endocrine specialists from across Europe and the world to collaborate and celebrate endocrinology.

Pancreas cells secrete neuroprotective factor

Researchers discovered that pancreatic β cells produce a neuroprotective agent called Fibroblast Growth Factor 23 (FGF23), which can stop amyloid-β-induced neuronal cell death. FGF23 may increase ribosomal proteins, helping to maintain homeostasis in neurons.

SourcePNAS Nexus·JournalPNAS Nexus·DateJan 28, 2025

Boosting this molecule could help retain muscle while losing fat

A new study from the Salk Institute has discovered that a protein called BCL6 plays a crucial role in maintaining healthy muscle mass. Increasing BCL6 levels successfully reversed muscle losses in mice, suggesting that pairing GLP-1 medications with a BCL6-boosting drug could help counteract unwanted muscle loss.

SourceSalk Institute·JournalProceedings of the National Academy of Sciences·DateJan 23, 2025

Insurance coverage, type of employment shape inequities in access to semaglutide

A new study found disparities in access to semaglutide based on insurance plan, job industry, sex, and other factors. Individuals with female identities, preferred provider organization coverage, and antidepressant use were more likely to start taking semaglutide compared to males or those with certain employment industries.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateJan 22, 2025

Study identifies benefits, risks linked to popular weight-loss drugs

A recent study published in Nature Medicine analyzed over 2 million veterans taking GLP-1RA medications, finding benefits to cognitive and behavioral health while revealing increased risks for pancreatitis and kidney conditions. The study also showed decreased risks of seizures, addiction, suicidal ideation, and neurocognitive disorders.

SourceWashington University in St. Louis·JournalNature Medicine·TypeData/statistical analysis·DateJan 20, 2025

Many Greenlanders face 10 times higher risk of diabetes – exercise may be their only solution

A study published in Nature Metabolism found that four percent of Greenland's Inuit population has a gene variant that increases their risk of type 2 diabetes by tenfold. Exercise has been shown to increase insulin sensitivity in these individuals, suggesting it may be an effective way to reduce their risk of developing the disease.

SourceUniversity of Copenhagen - Faculty of Science·JournalNature Metabolism·DateJan 19, 2025

Radon exposure and gestational diabetes

A cohort study found that individuals with higher radon exposure are at a greater risk of developing gestational diabetes during pregnancy. The study suggests a potential link between radon exposure and metabolic health in nulliparous pregnant women.

SourceJAMA Network·JournalJAMA Network Open·DateJan 10, 2025

New glucose monitoring method could revolutionize diabetes management by eliminating finger-sticks for blood samples

Researchers at Binghamton University have developed a new paper-based biosensor system that uses bacterial spores to monitor glucose levels in sweat, eliminating the need for finger-stick devices. The system is shelf-stable, self-replicating, and can endure harsh environments, making it a promising alternative for diabetes management.

SourceBinghamton University·JournalMicrosystems & Nanoengineering·DateJan 9, 2025

Expanded research on COPD and metabolic syndrome would advance patient-centered care

Additional research is required to explore the relationship between COPD and metabolic syndrome, focusing on outcomes, intervention trials, and health services research. This will help shift from a COPD-focused approach to an integrated care approach considering all comorbidities.

SourceCOPD Foundation·JournalChronic Obstructive Pulmonary Diseases Journal of the COPD Foundation·TypeCommentary/editorial·DateJan 9, 2025

Poor vascular health accelerates brain ageing

Researchers at Karolinska Institutet used AI to analyze brain images from 70-year-olds and found that factors like inflammation and high glucose levels are associated with an older-looking brain. A healthy lifestyle, on the other hand, was linked to brains with a younger appearance.

SourceKarolinska Institutet·JournalAlzheimer s & Dementia·TypeObservational study·DateDec 20, 2024

Combined screening can detect liver damage in diabetes patients

A new study published in Lancet Gastroenterology and Hepatology found that a combined screening approach can detect liver damage in people with type 2 diabetes. The method involves elastography, an ultrasound-based technique, which was found to be willing to be adopted by most patients. Early detection of liver fibrosis is crucial, as ...

SourceKarolinska Institutet·JournalThe Lancet Gastroenterology & Hepatology·DateDec 12, 2024